He has consulted Gilead Sciences. Shionogi and Assembly Biosciences ... an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new ...

NORTHAMPTON, MA / ACCESS Newswire / June 24, 2025 / Kim Canady was only nine years old in 1996 when she faced the ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...

Gilead Sciences chairman and CEO Daniel O’Day joins 'Squawk Box' to discuss the FDA approval of the company's HIV prevention ...

National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...

A drug used to treat some HIV infections can now be used to help prevent HIV, the virus that causes AIDS. On June 18, lenacapavir, a twice-yearly injection from Gilead Sciences, gained approval from ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...